[Prevalence of the use of anabolic agents among strength training apprentices in Porto Alegre, RS].
This study aimed to determine through a questionnaire applied to interviewers, the current or past use of anabolic androgenic steroids (AAS), as well as other hormones (OH), and other medicines (OM), food supplement and illicit drugs among strength training apprentices in the city of Porto Alegre, RS. We interviewed 288 subjects draw from a sample of 13 gyms. The prevalence of current and past use of AAS was about 11.1% (32/288), OH 5.2% (16/288) and OM 4.2% (12/288). The most used AAS were nandrolone and stanozolol; the OH were gonadotropin, triiodothyronine (T3) and OM, like lipostabil, diuretics and veterinary medicines (Monovin E). The most frequent side-effects were behavioral such as humor oscillation, irritability and hostility, and endocrine disturbances such as acne and increased or decreased libido. When analyzed together with other hormones in a variable named "hormonal agents" (AH), AAS presented a statistical difference (p< 0.05) among genders considering that the most frequent use of AH occurred among men and those who consume food supplements. The comparison of these findings to other national and international results is difficult due to the epidemiological design. Even if it is considered, the observed prevalence suggests that preventive attitudes as well as special care in the orientation and education of this population must be taken.
Silva
Paulo R P da
PR
Faculdade de Medicina, UFRGS, RS.
Machado
Leonel C
LC
Figueiredo
Vandré C
VC
Cioffi
Alex P
AP
Prestes
Marcius C
MC
Czepielewski
Mauro A
MA
D000328:Adult; D000367:Age Factors; D045930:Anabolic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000728:Androgens / Q000008:administration & dosage* / Q000009:adverse effects; D001938:Brazil / Q000453:epidemiology; D004300:Doping in Sports / Q000706:statistics & numerical data*; D004522:Educational Status; D015444:Exercise / Q000502:physiology*; D005260:Female; D020446:Fitness Centers / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D009277:Nandrolone / Q000008:administration & dosage / Q000009:adverse effects; D015995:Prevalence; D012737:Sex Factors; D013197:Stanozolol / Q000008:administration & dosage / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000453:epidemiology*
D045930:Anabolic Agents; D000728:Androgens; D013197:Stanozolol; D009277:Nandrolone